RhumbLine Advisers’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-659
| Closed | -$3.4K | – | 4364 |
|
|
2024
Q2 | $3.4K | Hold |
659
| – | – | ﹤0.01% | 4138 |
|
|
2024
Q1 | $3.53K | Hold |
659
| – | – | ﹤0.01% | 4029 |
|
|
2023
Q4 | $5.13K | Hold |
659
| – | – | ﹤0.01% | 3977 |
|
|
2023
Q3 | $2.6K | Hold |
659
| – | – | ﹤0.01% | 4085 |
|
|
2023
Q2 | $2.08K | Buy |
+659
| New | +$2.08K | ﹤0.01% | 4211 |
|
|
2022
Q2 | – | Sell |
-6,387
| Closed | -$76K | – | 3259 |
|
|
2022
Q1 | $76K | Sell |
6,387
-279
| -4% | -$3.32K | ﹤0.01% | 2937 |
|
|
2021
Q4 | $217K | Sell |
6,666
-11
| -0.2% | -$358 | ﹤0.01% | 2815 |
|
|
2021
Q3 | $298K | Buy |
6,677
+205
| +3% | +$9.15K | ﹤0.01% | 2769 |
|
|
2021
Q2 | $353K | Buy |
6,472
+1,802
| +39% | +$98.3K | ﹤0.01% | 2725 |
|
|
2021
Q1 | $349K | Sell |
4,670
-78
| -2% | -$5.83K | ﹤0.01% | 2643 |
|
|
2020
Q4 | $515K | Buy |
4,748
+259
| +6% | +$28.1K | ﹤0.01% | 2436 |
|
|
2020
Q3 | $397K | Sell |
4,489
-403
| -8% | -$35.6K | ﹤0.01% | 2394 |
|
|
2020
Q2 | $522K | Buy |
4,892
+947
| +24% | +$101K | ﹤0.01% | 2326 |
|
|
2020
Q1 | $234K | Buy |
3,945
+6
| +0.2% | +$356 | ﹤0.01% | 2518 |
|
|
2019
Q4 | $272K | Buy |
3,939
+46
| +1% | +$3.18K | ﹤0.01% | 2642 |
|
|
2019
Q3 | $404K | Sell |
3,893
-27
| -0.7% | -$2.8K | ﹤0.01% | 2424 |
|
|
2019
Q2 | $363K | Buy |
3,920
+780
| +25% | +$72.2K | ﹤0.01% | 2507 |
|
|
2019
Q1 | $287K | Sell |
3,140
-101
| -3% | -$9.23K | ﹤0.01% | 2571 |
|
|
2018
Q4 | $181K | Buy |
3,241
+1,100
| +51% | +$61.4K | ﹤0.01% | 2762 |
|
|
2018
Q3 | $255K | Sell |
2,141
-106
| -5% | -$12.6K | ﹤0.01% | 2602 |
|
|
2018
Q2 | $229K | Buy |
2,247
+1,049
| +88% | +$107K | ﹤0.01% | 2676 |
|
|
2018
Q1 | $155K | Buy |
1,198
+172
| +17% | +$22.3K | ﹤0.01% | 2658 |
|
|
2017
Q4 | $100K | Sell |
1,026
-247
| -19% | -$24.1K | ﹤0.01% | 2774 |
|
|
2017
Q3 | $187K | Buy |
1,273
+41
| +3% | +$6.02K | ﹤0.01% | 2766 |
|
|
2017
Q2 | $198K | Buy |
+1,232
| New | +$198K | ﹤0.01% | 2764 |
|